X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (5) 5
risk factors (5) 5
female (4) 4
male (4) 4
type 2 diabetes (4) 4
aged (3) 3
analysis (3) 3
benzhydryl compounds - adverse effects (3) 3
dapagliflozin (3) 3
diabetes (3) 3
diabetes mellitus, type 2 - drug therapy (3) 3
double-blind (3) 3
glucosides - adverse effects (3) 3
hypoglycemic agents - adverse effects (3) 3
inadequate glycemic control (3) 3
medicine & public health (3) 3
middle aged (3) 3
thromboembolism (3) 3
abridged index medicus (2) 2
add-on therapy (2) 2
adult (2) 2
anticoagulants - therapeutic use (2) 2
blood-pressure (2) 2
canagliflozin - adverse effects (2) 2
cardiology (2) 2
cardiovascular diseases (2) 2
cardiovascular diseases - epidemiology (2) 2
care and treatment (2) 2
clinical trials (2) 2
complications and side effects (2) 2
deep-vein thrombosis (2) 2
diabetes mellitus (2) 2
drug therapy (2) 2
endocrinology & metabolism (2) 2
fractures, bone - chemically induced (2) 2
fractures, bone - epidemiology (2) 2
glomerular filtration rate - drug effects (2) 2
incidence (2) 2
internal medicine (2) 2
kidney failure (2) 2
kidneys (2) 2
long-term (2) 2
medicine, general & internal (2) 2
peripheral vascular disease (2) 2
pharmacology/toxicology (2) 2
pharmacotherapy (2) 2
placebo-controlled trial (2) 2
prevention (2) 2
randomized controlled trials as topic (2) 2
risk (2) 2
secondary prevention (2) 2
sodium (2) 2
sodium-glucose transporter 2 - antagonists & inhibitors (2) 2
thromboembolism - prevention & control (2) 2
treatment outcome (2) 2
venous thromboembolism (2) 2
24-week (1) 1
28-week extension (1) 1
ace inhibitors (1) 1
acute kidney injury (1) 1
adherence (1) 1
age factors (1) 1
aged patients (1) 1
amputation (1) 1
angiotensin (1) 1
anticoagulant (1) 1
anticoagulants - administration & dosage (1) 1
arterial (1) 1
aspirin - therapeutic use (1) 1
bandages (1) 1
benzhydryl compounds - administration & dosage (1) 1
benzhydryl compounds - pharmacology (1) 1
benzhydryl compounds - therapeutic use (1) 1
blood pressure - drug effects (1) 1
blood urea nitrogen (1) 1
body-weight (1) 1
brief report (1) 1
brief reports (1) 1
canagliflozin (1) 1
canagliflozin - therapeutic use (1) 1
cardiac & cardiovascular systems (1) 1
cardiovascular diseases - mortality (1) 1
cardiovascular diseases - prevention & control (1) 1
cardiovascular risk-factors (1) 1
cerebral infarction (1) 1
chronic (1) 1
clinical focus (1) 1
clinical outcomes (1) 1
clinical trial (1) 1
clinical trials as topic (1) 1
clinical trials, phase ii as topic (1) 1
clinical trials, phase iii as topic (1) 1
collaboration (1) 1
control (1) 1
controlled-trial (1) 1
creatinine (1) 1
creatinine - blood (1) 1
critical care medicine (1) 1
dalteparin sodium (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 24, pp. 2295 - 2306
Journal Article
Drugs & Aging, ISSN 1170-229X, 7/2016, Volume 33, Issue 7, pp. 511 - 522
To evaluate the 104-week safety of dapagliflozin in older patients with type 2 diabetes mellitus.Pooled analysis assessing general safety (nine phase III... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | RANDOMIZED-CONTROLLED-TRIAL | ACUTE KIDNEY INJURY | ADD-ON THERAPY | 28-WEEK EXTENSION | DOUBLE-BLIND | INHIBITOR DAPAGLIFLOZIN | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | INADEQUATE GLYCEMIC CONTROL | BLOOD-PRESSURE | CARDIOVASCULAR RISK-FACTORS | GERIATRICS & GERONTOLOGY | Hypoglycemia - epidemiology | Benzhydryl Compounds - administration & dosage | Humans | Middle Aged | Fractures, Bone - epidemiology | Male | Clinical Trials, Phase III as Topic | Benzhydryl Compounds - adverse effects | Hypoglycemic Agents - administration & dosage | Urinary Tract Infections - chemically induced | Cardiovascular Diseases - epidemiology | Adult | Female | Glucosides - therapeutic use | Safety | Hypoglycemia - chemically induced | Benzhydryl Compounds - therapeutic use | Glucosides - adverse effects | Kidney - physiopathology | Hypoglycemic Agents - therapeutic use | Risk Factors | Urinary Tract Infections - epidemiology | Glucosides - administration & dosage | Aged | Diabetes Mellitus, Type 2 - drug therapy | Fractures, Bone - chemically induced | Hypoglycemic Agents - adverse effects | Clinical Trials, Phase II as Topic | Type 2 diabetes | Care and treatment | Usage | Dapagliflozin | Clinical trials | Aged patients | Dosage and administration | Health aspects | Original
Journal Article
Diabetes Therapy, ISSN 1869-6953, 3/2016, Volume 7, Issue 1, pp. 125 - 137
Journal Article
JAMA, The Journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 21, p. 2295
The article reports on a study to evaluate the safety and efficacy of canagliflozin in improving renal outcomes in patients with type 2 diabetes and... 
Type 2 diabetes | Treatment outcome | Complications and side effects | Kidney failure | Analysis | Drug therapy | Risk factors
Journal Article
Postgraduate Medicine, ISSN 0032-5481, 05/2016, Volume 128, Issue 4, pp. 346 - 355
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 2005, Volume 16, Issue 4, pp. 257 - 266
New anticoagulants are under development to improve on current ones that, although effective, have limitations in efficacy, safety and convenience. We have... 
Thromboembolism | New anticoagulants | Venous | Arterial | Prophylaxis | Prevention | Protein C | Thrombin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.